Physician profile
William E Swanson
NPI 1194832774
$572.97
in general payments reported to CMS, 2019-2025
14 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.20 · 2022: $67.34 · 2023: $86.44 · 2024: $196 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $116.74 | 2024-2025 | Adstiladrin |
| Teleflex LLC | $84.54 | 2023-2024 | Urolift |
| Abbvie INC. | $63.63 | 2023-2025 | Botox |
| Urogen Pharma, INC. | $59.45 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $37.94 | 2023-2024 | Gemtesa |
| Baudax Bio INC. | $31.95 | 2021 | |
| Laborie Medical Technologies Corp. | $31.32 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $27.55 | 2025 | Xiaflex |
| Civco Medical Instruments | $26.27 | 2023 | |
| Accord Healthcare, INC. | $23.58 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $19.91 | 2022 | |
| Myriad Genetic Laboratories, INC. | $19.50 | 2024 | Prolaris |
| Immunitybio, INC. | $19.34 | 2025 | |
| Allergan, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.